Abstract: An apparatus and method for processing a substrate can reduce the concentration of process by-products in a chemical solution.

Abstract: The present invention relates to a pharmaceutical composition, for treating glioblastoma, comprising a nucleic acid complex as an active ingredient and, more particularly, to a pharmaceutical composition, for preventing or treating glioblastoma, comprising a nucleic acid complex having complementarily bound: a bioactive peptide nucleic acid having a sequence binding to TGF-?2 gene; and a carrier peptide nucleic acid. The nucleic acid complex according to the present invention has excellent cell permeability and intracellular activity and can effectively inhibit the expression of TGF-?2 gene and the hypostatic gene thereof, and thus is useful in preventing or treating glioblastoma.

Abstract: Provided is a method of manufacturing syngas including (S1) heat-treating organic wastes under a catalyst in a first reactor to produce a first mixed gas; (S2) separating the catalyst and carbon dioxide (CO2) from the first mixed gas, and recovering a mixed gas from which the catalyst and the carbon dioxide (CO2) have been removed; (S3) converting the carbon dioxide (CO2) separated in (S2) into carbon monoxide (CO) by a reverse Boudouard reaction in a second reactor; and (S4) mixing the mixed gas recovered in (S2) and the carbon monoxide (CO) converted in (S3) to produce syngas.

Abstract: Disclosed is a secondary battery pouch film, including an outer layer, a metal layer, and a sealant layer, wherein the sealant layer includes a cast polypropylene (CPP) layer and an extruded polypropylene (PP) layer, and the secondary battery pouch film satisfies the [Equation 1] where A+B<1.354, 0.6?C. In [Equation 1], A is a value obtained by dividing a thickness of the metal layer by a total thickness of the secondary battery pouch film, B is a value obtained by dividing a thickness of the metal layer by a thickness of the sealant layer, and C is a value obtained by dividing a thickness of the extruded polypropylene (PP) layer of the sealant layer by a thickness of the cast polypropylene (CPP) layer of the sealant layer. The pouch film has excellent formability, curling, insulation, bending, and peel strength.

Abstract: Proposed is a polyolefin resin having excellent processability, toughness, and bubble stability, thereby being useful for molding into shrinkage films, agricultural films, etc. A method of preparing the same polyolefin resin is also proposed.

Abstract: The present invention relates to a benzothiazole or benzimidazole derivative, a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising same as an active ingredient for prevention or treatment of SIRTUIN 7 protein-related diseases. With excellent inhibitory activity against SIRTUIN 7 protein the derivative can be used for preventing or treating SIRTUIN 7 protein-related diseases.

Abstract: Proposed are an unsupported metallic catalyst for a selective ring-opening (SRO) reaction and a method of using the same catalyst, wherein the catalyst contains nickel (Ni), molybdenum (Mo), and tungsten (W).

Abstract: Disclosed are an anti-fingerprint film for automobile interiors and methods of producing the same. The anti-fingerprint film for automobile interior parts may include a base layer and an outermost layer located on the base layer including a fluorine-based compound, thus reducing the attachment area of the fingerprint composed of water and oil by virtue of the outermost layer having high water and oil repellency, ultimately removing fingerprint visibility.

Abstract: The present invention relates to an electrolyte solution and a secondary battery including the same. According to the present invention, the present invention has an effect of providing a secondary battery having improved charging efficiency and output due to low discharge resistance and having a long lifespan and excellent high-temperature capacity retention by suppressing gas generation and increase in thickness.

Abstract: The present invention relates to an electrolyte solution and a secondary battery including the same. According to the present invention, the present invention has an effect of providing a secondary battery having improved charging efficiency and output due to low discharge resistance and having a long lifespan and excellent high-temperature capacity retention by suppressing gas generation and increase in thickness.

Abstract: The present invention relates to an electrolyte solution and a secondary battery including the same. According to the present invention, the present invention has an effect of providing a secondary battery having improved charging efficiency and output due to low discharge resistance and having a long lifespan and excellent high-temperature capacity retention by suppressing gas generation and increase in thickness.

Abstract: The present invention relates to an electrolyte solution and a secondary battery including the same. According to the present invention, the present invention has an effect of providing a secondary battery having improved charging efficiency and output due to low discharge resistance and having a long lifespan and excellent high-temperature capacity retention by suppressing gas generation and increase in thickness.

Abstract: Provided is a peptide composition for preventing or treating Alzheimer's dementia. A peptide or a salt substituent thereof according to the presently claimed subject matter exhibits effects such as suppression of LPS-mediated cytokine production, suppression of LPS-induced neuroinflammation, amelioration of cognitive impairment, suppression of beta amyloid or tau protein aggregation, and suppression of neuronal loss. The polypeptide or the salt substituent thereof can permeate the blood-brain barrier, and thus, is expected to be usefully used for preventing or treating Alzheimer's dementia.

Abstract: It is disclosed a blood glucose prediction system and method using saliva-based artificial intelligence deep learning technique.

Abstract: The present invention relates to a novel-structured nucleic acid complex having a blood-brain barrier penetration ability and a composition comprising same and, more specifically, to a nucleic acid complex in which a bioactive nucleic acid is complementarily bound to a carrier peptide nucleic acid modified to be generally positively charged, and to a composition for blood-brain barrier penetration comprising same. The nucleic acid complex according to the present invention can penetrate the blood-brain barrier at excellent efficiency, and especially, the conjugation of a drug into the nucleic acid complex increases the blood-brain barrier penetration ability of the drug, and thus is very useful in treatment or diagnosis of diseases.

Abstract: A method for controlling a vehicle includes: determining an accelerator position sensor/brake pedal position sensor (APS/BPS) command value based on a state variable and a reward variable including a prediction value for a future velocity of the vehicle predicted based on a past APS/BPS command value of the vehicle; and learning for a reward value according to the reward variable to satisfy a predetermined goal based on a change that the determined APS/BPS command value causes to at least one state variable under given environment information.

Abstract: The electronic device for diagnosing dementia with Lewy bodies (DLB) or predicting morbidity to DLB according to the present invention includes a processor that measures cortical thicknesses for a plurality of regions of the brain by using brain MRI images of a normal group and a DLB patient group, generates a DLB pattern matrix by using a residual matrix according to a difference between the average cortical thickness and the cortical thickness for each region, applies a first cortical thickness matrix generated by using a brain MRI image of the subject to the DLB pattern to calculate a first DLB pattern score, and diagnoses the subject as DLB or predicting morbidity to DLB by using the first DLB pattern score.

Abstract: An electronic device and a control method therefor are disclosed. The disclosed electronic device includes an input part, a communication part, a processor, and a memory, wherein the memory may include instructions for controlling the communication part such that the processor requests identification information including a call word for using an artificial intelligence assistant function to another electronic device when an event for requesting configuration of a first mode in which the artificial intelligence assistant function of the other electronic device can be used occurs, for controlling the communication part to receive the identification information from the other electronic device through the communication part in response to the request, and transmit a user command to the other electronic device based on the identification information if the user command is received during operation of the first mode of the artificial intelligence assistant.

Abstract: A power conversion device for controlling a DC voltage of a DC link may comprise a first diode, a second diode, a first switching element, a second switching element, a third switching element, and a fourth switching element, wherein: a cathode terminal of the first diode is connected to a positive terminal of the DC link; an anode terminal of the first diode is connected to one end of the first switching element and one end of the third switching element; the other end of the first switching element is connected to an alternating current terminal and one end of the second switching element; the other end of the second switching element is connected to one end of the second diode and one end of the fourth switching element; the other end of the second diode is connected to a negative terminal of the DC link.